SCHEMBL23309603

SCHEMBL23309603

O=C(Nc1ccccc1Cl)c1cc(F)nc(F)c1F

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.56
▸ HPGD P15428 1/20 0.56
▸ CYP2C19 P33261 1/20 0.56
▸ NPC1 O15118 4/20 0.50
▸ POLB P06746 1/20 0.50
▸ CASP3 P42574 1/20 0.50
▸ ATM Q13315 1/20 0.50
▸ SENP8 Q96LD8 1/20 0.50
▸ SENP7 Q9BQF6 1/20 0.50
▸ SENP6 Q9GZR1 1/20 0.50
▸ RAB9A P51151 4/20 0.48
▸ EPHB3 P54753 5/20 0.47
▸ KMT2A Q03164 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ RIPK2 O43353 1/20 0.46
▸ LCK P06239 1/20 0.46
▸ AR P10275 1/20 0.45
▸ CBR1 P16152 1/20 0.45
▸ AKR1C3 P42330 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309595 0.89 EPHB3 (0.47) CYP1A2HPGDCYP2C19NPC1POLB
SCHEMBL23309697 0.83 HTT (0.56) CYP1A2HPGDCYP2C19NPC1POLB
SCHEMBL23309709 0.80 EPHB3 (0.50) CYP1A2NPC1POLBRAB9AEPHB3
SCHEMBL23309546 0.80 NFKB1 (0.50) NPC1RAB9AKMT2A
SCHEMBL23309490 0.80 GAA (0.51) HPGDNPC1POLBRAB9AKMT2A
SCHEMBL23309502 0.80 NFKB1 (0.51) HPGDNPC1POLBRAB9AKMT2A
SCHEMBL23309730 0.77 KMT2A (0.47) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL23309708 0.77 RAB9A (0.52) NPC1POLBRAB9AKMT2ASMN1; SMN2
SCHEMBL23309548 0.77 FADS1 (0.55) HPGDNPC1ATMRAB9AKMT2A
SCHEMBL23309495 0.77 FADS1 (0.56) NPC1RAB9AKMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL CYP1A2 1133/4885HPGD 3625/4885CYP2C19 1844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback